Rankings
▼
Calendar
NVAX Q2 2018 Earnings — Novavax, Inc. Revenue & Financial Results | Market Cap Arena
NVAX
Novavax, Inc.
$2B
Q2 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$11M
+60.0% YoY
Gross Profit
$11M
100.0% margin
Operating Income
-$42M
-389.8% margin
Net Income
-$44M
-413.0% margin
EPS (Diluted)
$-2.37
QoQ Revenue Growth
+11.6%
Cash Flow
Operating Cash Flow
-$40M
Free Cash Flow
-$40M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$286M
Total Liabilities
$374M
Stockholders' Equity
-$88M
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$11M
$7M
+60.0%
Gross Profit
$11M
$7M
+60.0%
Operating Income
-$42M
-$41M
-1.3%
Net Income
-$44M
-$44M
-0.1%
← FY 2018
All Quarters
Q3 2018 →